Personal Experience of Colorectal Cancer is an Irreverent, Cheeky Tail of Surviving, Thriving and Transforming Through Illness

Are You S***ting Me?! How to Survive, Thrive and Transform Through Colorectal Cancer, written by Oils & Spoils blogger Kim Mullins, is available for pre-order through 1 a.m., April 22. Are You S***ting Me?! is an irreverent, yet informational play-by-play of how to navigate, understand and plan for surviving, thriving and transforming through illness. “Personal experiences of … Read more

Mitolytix: Mitochondrial Targeting to Treat Cancer Shows Promise in Early Studies

Demonstrating efficacy across multiple types of cancers, data showed that a unique biomolecule targeting malignant cells from the metabolic perspective — as complex I dysfunctions in energy metabolism (NADH-ubiquinone oxidoreductase complex I dysfunction) — has tremendous potential for increasing overall survival rates in patients with cancers that express with free radical dysfunction, a predisposing hallmark … Read more

Convergence of Targeted Drugs With Genomics-Based Diagnostics to Create New Paradigm for Cancer Treatment

Big Data is our greatest potential weapon in the fight against cancer. Despite countless advancements, cancer remains the second-leading cause of death worldwide, and the burden on patients, families and society is profound. Advanced diagnostics for cancer represent a major market opportunity for life sciences companies, according to the BCC Research report, Next-Generation Cancer Diagnostics: Technologies and … Read more

Alex’s Lemonade Stand Foundation Awards More Than $18.5 Million to Recipients of Crazy 8 Initiative to Advance Pediatric Cancer Research

Alex’s Lemonade Stand Foundation (ALSF), a nonprofit foundation devoted to finding cures for children with cancer, announces grant award recipients of their Crazy 8 Initiative. The recipients will receive grants totaling more than $18.5 million, which is the single, largest funding commitment from ALSF to date. The Initiative kicked off in the Fall of 2018 with … Read more

DoseOptics Receives FDA 510(k) Clearance for BeamSite™

DoseOptics LLC announced today that it has received 510(k) clearance for BeamSite™ by the US Food and Drug Administration. Radiation therapy is a powerful tool used by oncologists to provide curative treatments to over a million patients per year in the US, and where one out of every four US citizens will receive it in … Read more